COVID-19: Oxford jab scientist set for £20m windfall in 'New York flotation'

The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of £20m through a stock market listing, according to reports.

The full article is no longer available.